The biotech giant is bucking the market trend, but its real value for investors lies in a story that unfolds over years, not ...

Amgen stock snapshot and recent performance Amgen (AMGN) is drawing attention after recent price moves, with the stock last ...

Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Major market indexes such as the S&P 500 declined in the first few months of the year, but have since rebounded significantly. In contrast, biotech giant Amgen (NASDAQ: AMGN) started the year strong, ...

With a market cap of $181.8 billion, Amgen Inc. (AMGN) is a global biotechnology company that discovers, develops, ...

The biotech and pharmaceutical mainstay posted its third-quarter results. It was a beat-and-raise quarter that featured double-digit growth on the top line. The quarter saw Amgen lift its total ...

Amgen's weight management candidate looks very promising. The large biotech boasts a deep pipeline beyond that segment. Amgen's dividend looks great, and the stock is reasonably valued. Even so, there ...